Advertisement

Prognostic utility of splenic response ratio in dipyridamole PET myocardial perfusion imaging

  • Karan Bami
  • Shrankhala Tewari
  • Fadi Guirguis
  • Linda Garrard
  • Ann Guo
  • Alomgir Hossain
  • Terrence D. Ruddy
  • Rob S. B. Beanlands
  • Robert A. deKemp
  • Benjamin J. W. Chow
  • Girish Dwivedi
Original Article

Abstract

Background

Cardiac magnetic resonance perfusion studies with adenosine stress have shown that splenic response can identify patients with inadequate pharmacologic stress. We investigate the incremental prognostic impact of splenic response ratio (SRR) in patients with normal Rubidium (Rb)-82 PET myocardial perfusion imaging (MPI).

Methods

Consecutive patients undergoing dipyridamole Rb-82 PET MPI for the evaluation of coronary artery disease were screened. Spleen and liver Rb-82 activity was measured and the SRR was calculated: SRR = (Spleen stress/Liver stress)/(Spleen rest/Liver rest). Major adverse cardiac events (MACE) were determined at 1 year of follow-up in patients with normal summed stress score and normal summed difference score.

Results

Of the 839 patients screened, the spleen was visualized in 703 (84%) of scans. There was significantly higher MACE observed in splenic non-responders vs splenic responders in both the normal SSS (7.8% vs 2.9%, P = .027) and the normal SDS groups (7.4% vs 2.2%, P = .014). In multivariate analysis in patients with normal SDS, splenic response was a significant, independent predictor of MACE (HR 2.97, 95% CI 1.10 to 8.04, P = .033).

Conclusions

SRR is a novel imaging metric to identify patients with sub-maximal vasodilator stress and an incremental prognostic marker in patients with normal SDS and SSS (Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT01128023).

Keywords

Major adverse cardiac events myocardial perfusion imaging positron emission tomography prognosis summed difference score splenic response ratio 

Abbreviations

HD

Hemodynamic

CT

Computed tomography

MACE

Major adverse cardiac events

MFR

Myocardial blood flow reserve

MPI

Myocardial perfusion imaging

PET

Positron emission tomography

Rb

Rubidium

SDS

Summed difference score

SRR

Splenic response ratio

SSS

Summed stress score

Notes

Disclosures

Karan Bami, Shrankhala Tewari, Fadi Guirguis, Linda Garrard, and Ann Guo have nothing to disclose. Terrence D. Ruddy has research grants from GE HealthCare and Advanced Accelerator Applications. Robert A. deKemp reports grants, consulting fees, and license revenues from Jubilant DraxImage and University of Ottawa Heart Institute (UOHI), outside the submitted work. Rob S. B. Beanlands reports grants and honoraria from Lantheus Medical Imaging, grants and honoraria from Jubilant DraxImage, and grants from GE Healthcare, outside the submitted work. Rob S. B. Beanlands is a Career Investigator supported but the Heart and Stroke Foundation of Ontario and a Tier 1 Research Chair supported by the University of Ottawa. Benjamin J. W. Chow holds the Saul and Edna Goldfarb Chair in Cardiac Imaging Research. He receives research support from CV Diagnostix and educational support from TeraRecon Inc. Girish Dwivedi was supported by a CIHR new investigator salary support award while at UOHI. Currently he is Wesfarmers Chair in Cardiology at University of Western Australia with an Adjunct Professor appointment at UOHI. The study was performed at UOHI.

Supplementary material

12350_2018_1269_MOESM1_ESM.pptx (1.5 mb)
Supplementary material 1 (PPTX 1539 kb)
12350_2018_1269_MOESM2_ESM.doc (56 kb)
Supplementary material 2 (DOC 55 kb)

References

  1. 1.
    Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-analysis. J Am Coll Cardiol. 2012;60:1828-37.CrossRefPubMedGoogle Scholar
  2. 2.
    Sampson UK, Dorbala S, Limaye A, Kwong R, Di Carli MF. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol. 2007;49:1052-8.CrossRefPubMedGoogle Scholar
  3. 3.
    Kidambi A, Sourbron S, Maredia N, Motwani M, Brown JM, Nixon J, et al. Factors associated with false-negative cardiovascular magnetic resonance perfusion studies: A clinical evaluation of magnetic resonance imaging in coronary artery disease (CE-MARC) substudy. J Magn Reson Imaging. 2016;43:566-73.CrossRefPubMedGoogle Scholar
  4. 4.
    Sandler MP, Kronenberg MW, Forman MB, Wolfe OH, Clanton JA, Partain CL. Dynamic fluctuations in blood and spleen radioactivity: Splenic contraction and relation to clinical radionuclide volume calculations. J Am Coll Cardiol. 1984;3:1205-11.CrossRefPubMedGoogle Scholar
  5. 5.
    Hunter CR, Hill J, Ziadi MC, Beanlands RS, deKemp RA. Biodistribution and radiation dosimetry of (82)Rb at rest and during peak pharmacological stress in patients referred for myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2015;42:1032-42.CrossRefPubMedGoogle Scholar
  6. 6.
    Bryant JAA, Harden S, George S, Shambrook J, Peebles C. Early clinical experience with “splenic switch-off” in adenosine stress CMR. J Cardiovasc Magn Reson. 2015;17:91.CrossRefGoogle Scholar
  7. 7.
    Manisty C, Ripley DP, Herrey AS, Captur G, Wong TC, Petersen SE, et al. Splenic switch-off: A tool to assess stress adequacy in adenosine perfusion cardiac MR imaging. Radiology. 2015;276:732-40.CrossRefPubMedGoogle Scholar
  8. 8.
    Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58:740-8.CrossRefPubMedGoogle Scholar
  9. 9.
    Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction.[Erratum appears in Circulation 1998 Jul 14;98(2):190]. Circulation. 1998;97:535-43.CrossRefPubMedGoogle Scholar
  10. 10.
    Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. J Am Coll Cardiol. 2004;43:200-8.CrossRefPubMedGoogle Scholar
  11. 11.
    Guntheroth WG, Mullins GL. Liver and spleen as venous reservoirs. Am J Physiol. 1963;204:35-41.PubMedGoogle Scholar
  12. 12.
    Mustafa SJ, Morrison RR, Teng B, Pelleg A. Adenosine receptors and the heart: Role in regulation of coronary blood flow and cardiac electrophysiology. Handb. 2009;193:161-88.Google Scholar
  13. 13.
    Fozard JR, Milavec-Krizman M. Contraction of the rat isolated spleen mediated by adenosine A1 receptor activation. Br J Pharmacol. 1993;109:1059-63.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Torres FS, Foppa M. Splenic switch-off for stress cardiovascular MR imaging and dipyridamole. Radiology. 2015;277:613-4.CrossRefPubMedGoogle Scholar
  15. 15.
    Wang T, Mentzer RM Jr, Van Wylen DG. Interstitial adenosine with dipyridamole: Effect of adenosine receptor blockade and adenosine deaminase. Am J Physiol. 1992;263(2 Pt 2):H552-8.PubMedGoogle Scholar
  16. 16.
    Senthamizhchelvan S, Bravo PE, Esaias C, Lodge MA, Merrill J, Hobbs RF, et al. Human biodistribution and radiation dosimetry of 82Rb. J Nucl Med. 2010;51(10):1592-9.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Conti A, Mariannini Y, Canuti E, Petrova T, Innocenti F, Zanobetti M, et al. Nuclear scan strategy and outcomes in chest pain patients value of stress testing with dipyridamole or adenosine. World J. 2014;13(2):94-101.Google Scholar

Copyright information

© American Society of Nuclear Cardiology 2018

Authors and Affiliations

  • Karan Bami
    • 1
  • Shrankhala Tewari
    • 1
  • Fadi Guirguis
    • 1
  • Linda Garrard
    • 1
  • Ann Guo
    • 1
  • Alomgir Hossain
    • 1
  • Terrence D. Ruddy
    • 1
  • Rob S. B. Beanlands
    • 1
  • Robert A. deKemp
    • 1
  • Benjamin J. W. Chow
    • 1
  • Girish Dwivedi
    • 1
    • 2
  1. 1.Division of Cardiology, Department of Medicine, National Cardiac PET Centre, University of Ottawa Heart Institute (UOHI)University of OttawaOttawaCanada
  2. 2.Harry Perkins Institute of Medical Research and Fiona Stanley Hospital (Murdoch)University of Western AustraliaNedlandsAustralia

Personalised recommendations